Cargando…
Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson’s Disease
Parkinson’s disease (PD) is a movement disorder caused by a dopamine deficit in the brain. Current therapies primarily focus on dopamine modulators or replacements, such as levodopa. Although dopamine replacement can help alleviate PD symptoms, therapies targeting the underlying neurodegenerative pr...
Autores principales: | Tandra, Gabriella, Yoone, Amy, Mathew, Rhea, Wang, Minzhi, Hales, Chadwick M., Mitchell, Cassie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418861/ https://www.ncbi.nlm.nih.gov/pubmed/37569714 http://dx.doi.org/10.3390/ijms241512339 |
Ejemplares similares
-
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
por: Ellegaard, Anne-Marie, et al.
Publicado: (2016) -
Identification of antiviral antihistamines for COVID-19 repurposing
por: Reznikov, Leah R., et al.
Publicado: (2021) -
Repurposing the Antihistamine Terfenadine for Antimicrobial
Activity against Staphylococcus aureus
por: Perlmutter, Jessamyn I., et al.
Publicado: (2014) -
Autologous Serum Therapy in Chronic Urticaria: A Promising Complement to Antihistamines
por: Debbarman, Panchami, et al.
Publicado: (2014) -
Ambivalent antihistamines.
Publicado: (1994)